BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Sarcomas

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. HERPUD1
    [Clinical Outcome] [